Blastic plasmacytoid dendritic cell neoplasm: a rare external ear lesion presenting with leukaemia

Hamad Dad Khan1, Sahil Kakar2, Lisha McClelland2

  • 1Department of Otorhinolaryngology and Head and Neck Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK hamaddaadkhan@gmail.com.

BMJ Case Reports
|September 21, 2024
PubMed

Insights

This case study details a rare aggressive blood cancer, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), presenting uniquely as an ear swelling. Diagnosis required extensive investigation due to initial misleading symptoms.

Area of Science:

  • Hematology
  • Oncology
  • Dermatology

Background:

  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy.
  • It typically presents with skin lesions and bone marrow involvement, posing diagnostic challenges.

Observation:

  • A unique case of a woman in her 70s presented with recurrent ear swelling initially mimicking a hematoma.
  • Initial diagnostic workup suggested vasculitis due to positive Myeloperoxidase (MPO) (p-ANCA) markers.
  • Steroid treatment provided temporary improvement but was associated with an elevated white cell count (WCC).

Findings:

  • Punch biopsy of the ear and bone marrow biopsy confirmed Blastic plasmacytoid dendritic cell neoplasm (BPDCN).
  • The patient was also diagnosed with concurrent chronic myelomonocytic leukaemia.
  • This case underscores the diagnostic complexity and varied presentations of BPDCN.

Implications:

  • Highlights the importance of multidisciplinary collaboration in diagnosing rare hematologic malignancies.
  • Expands the understanding of Blastic plasmacytoid dendritic cell neoplasm (BPDCN) presentations beyond typical cutaneous and bone marrow involvement.
  • Emphasizes the need for thorough hematological review when initial treatments yield ambiguous results or unexpected changes occur.